Tremfya on The Journal.

The Journal.June 3, 2026

Can the U.S. Keep Chinese Cars Out?

0:45
mid-roll
Kate Linebaugh, Ryan Knutson
The Wall Street Journal & Spotify Studios
June 3, 2026
UnknownBrand awarenessBaked-in adHealthcare
0:00 / 0:45
@ 3:08 in ep

Transcript

Tremfya guselkumab, taken by injection, is prescription medicine for adults with moderate to severe plaque psoriasis who may benefit from taking injections or pills or phototherapy. With Tremfya, clearer skin is possible. In clinical trials, at least seventy of patients saw at least 90% clearer skin at sixteen weeks. Results may vary. Tremfya is also indicated for adults with active psoriatic arthritis. Serious allergic reactions and increased risk of infections and liver problems may occur. Before treatment, your doctor should check you for infections and tuberculosis. Tell your doctor if you have an infection, flu like symptoms, or if you need a vaccine. Tap this ad to learn more about TREMFYA including important safety information.

Auto-transcribed · verbatim audio matches · Report an error

Estimated ad cost

~$960range $180$6,600

Estimate of what a similar one-episode podcast ad would cost based on rank, placement, and duration

Methodology and limitations →

Episode

The Journal.
Can the U.S. Keep Chinese Cars Out?
Hosts: Kate Linebaugh, Ryan Knutson
Publisher: The Wall Street Journal & Spotify Studios